Yes, administer a loading dose of aspirin (160 mg) immediately after excluding intracranial hemorrhage on neuroimaging.
For an acute frontal infarct presenting within 24 hours with an NIHSS score of approximately 6, aspirin should be loaded with 160 mg as soon as intracranial hemorrhage is ruled out on brain imaging 1. This recommendation is based on the most recent and comprehensive global stroke guidelines from 2023.
Rationale and Dosing Strategy
The 2023 World Stroke Organization guidelines explicitly state that patients with acute ischemic stroke or TIA who were not on an antiplatelet agent should receive a single loading dose of 160 mg aspirin after intracranial hemorrhage is excluded on neuroimaging 1. This applies to your patient with NIHSS 6, which falls into the category requiring immediate antiplatelet therapy.
Key Considerations for NIHSS 6:
- NIHSS 6 is NOT considered "minor" stroke (minor is defined as NIHSS ≤3) 1
- NIHSS 6 qualifies as "mild-moderate" stroke (NIHSS ≤5 in some definitions, though your patient is just above this threshold) 1
- For NIHSS 6, dual antiplatelet therapy (DAPT) with aspirin + clopidogrel or aspirin + ticagrelor should be strongly considered rather than aspirin monotherapy 1
Specific Treatment Algorithm for NIHSS 6:
Step 1: Confirm intracranial hemorrhage is excluded on CT/MRI
Step 2: Administer loading doses:
- Aspirin 300-325 mg loading dose (higher than the 160 mg for general acute stroke) 1
- Plus either:
- Clopidogrel 300-600 mg loading dose, OR
- Ticagrelor 180 mg loading dose 1
Step 3: Continue DAPT:
- If using aspirin-clopidogrel: aspirin 81 mg + clopidogrel 75 mg daily for 21 days 1
- If using aspirin-ticagrelor: aspirin 75-100 mg + ticagrelor 90 mg twice daily for 30 days 1
Step 4: After DAPT period, transition to single antiplatelet therapy (aspirin 81 mg or clopidogrel 75 mg daily) 1
Critical Timing Considerations:
- Initiate DAPT as early as possible, ideally within 12-24 hours of symptom onset 1
- The 2023 guidelines emphasize that for mild-moderate strokes (NIHSS ≤5), DAPT should be started within 24 hours 1
- Your patient at NIHSS 6 is borderline but would likely benefit from DAPT given the evidence
Important Caveats:
If thrombolysis (tPA) was administered:
- Delay aspirin for 24 hours after tPA administration 2, 3
- Obtain 24-hour post-thrombolysis imaging to exclude hemorrhage before starting antiplatelet therapy 2, 3
- Early aspirin administration with tPA increases symptomatic intracranial hemorrhage risk (4.3% vs 1.6%) without improving outcomes 4
If patient cannot swallow:
- Administer rectal aspirin 325 mg daily or aspirin 81 mg via enteral tube 1
Contraindications to check:
- Aspirin allergy or intolerance
- Active bleeding or recent gastrointestinal bleeding
- Need for oral anticoagulation (cardioembolic source)
- Severe thrombocytopenia
Evidence Strength:
The recommendation for aspirin loading in acute ischemic stroke is Class I, Level of Evidence A 1. The evidence demonstrates that aspirin reduces early recurrent ischemic stroke, death, and dependence when administered within 48 hours of stroke onset 2, 5, 3.
For NIHSS 6 specifically, consider DAPT over aspirin monotherapy as the patient falls into the mild-moderate range where DAPT has shown superior outcomes in preventing early recurrent stroke 1, 6. The ARAMIS trial demonstrated that DAPT is effective in minor nondisabling strokes, though your patient's NIHSS 6 may represent more significant disability depending on the specific deficits 6.